SPOTLIGHT: The top five regions targeting biotech


This year's list of top economic development efforts for biotechnology stays focused on the U.S., with five states that have stepped up to the plate with offers of significant financial support designed to spawn a new generation of drug developers. In many cases, these state programs are driving the development of new facilities that will likely have a profound impact in determining where the industry will find its most fertile soil for future growth. List

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.